Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Nephraegis Therapeutics
company
About
Nephraegis Therapeutics is a biopharmaceutical company developing NPH-022 to prevent and treat Acute Kidney Injury (AKI).
Highlights
Details
- Last Funding Type
- Seed
- Industries
- Biopharma,Biotechnology,Health Care,Medical,Therapeutics
- Founded date
- Jan 1, 2018
- Operating Status
- Active
Nephraegis Therapeutics is a biopharmaceutical company developing NPH-022 to prevent and treat Acute Kidney Injury (AKI).
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
—
Nephraegis Therapeutics has raised a total of
—
in funding over 2 rounds. Their latest funding was raised on
May 12, 2021 from a Seed round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| May 12, 2021 | Seed | — | 1 |
Xontogeny
|
— | Detail |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
